BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 8707417)

  • 1. Different ligand responsiveness of human retinoic-acid-receptor beta-gene transcription in tumorigenic and non-tumorigenic cervical-carcinoma-derived cell lines is mediated through a large retinoic-acid-response domain.
    Baust C; Redpath L; Schwarz E
    Int J Cancer; 1996 Jul; 67(3):409-16. PubMed ID: 8707417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level expression of the retinoic acid receptor beta gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor alpha and is abnormally down-regulated in cervical carcinoma cells.
    Geisen C; Denk C; Gremm B; Baust C; Karger A; Bollag W; Schwarz E
    Cancer Res; 1997 Apr; 57(8):1460-7. PubMed ID: 9108446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells.
    Bartsch D; Boye B; Baust C; zur Hausen H; Schwarz E
    EMBO J; 1992 Jun; 11(6):2283-91. PubMed ID: 1318198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line.
    Wan YJ; Cai Y; Magee TR
    Exp Cell Res; 1998 Jan; 238(1):241-7. PubMed ID: 9457077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
    Dey A; Ozato K
    Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells.
    Swisshelm K; Ryan K; Lee X; Tsou HC; Peacocke M; Sager R
    Cell Growth Differ; 1994 Feb; 5(2):133-41. PubMed ID: 8180126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific defect in the retinoic acid response associated with human lung cancer cell lines.
    Zhang XK; Liu Y; Lee MO; Pfahl M
    Cancer Res; 1994 Nov; 54(21):5663-9. PubMed ID: 7923214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism.
    Loudig O; Babichuk C; White J; Abu-Abed S; Mueller C; Petkovich M
    Mol Endocrinol; 2000 Sep; 14(9):1483-97. PubMed ID: 10976925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
    Li A; Zhu X; Craft CM
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines.
    Xu XC; Liu X; Tahara E; Lippman SM; Lotan R
    Cancer Res; 1999 May; 59(10):2477-83. PubMed ID: 10344761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a retinoic acid-inducible element in the murine PTH/PTHrP (parathyroid hormone/parathyroid hormone-related peptide) receptor gene.
    Karperien M; Farih-Sips H; Hendriks JA; Lanske B; Papapoulos SE; Abou-Samra AB; Löwik CW; Defize LH
    Mol Endocrinol; 1999 Jul; 13(7):1183-96. PubMed ID: 10406468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid receptor and retinoid X receptor expression in retinoic acid-resistant human tumor cell lines.
    van der Leede BM; van den Brink CE; van der Saag PT
    Mol Carcinog; 1993; 8(2):112-22. PubMed ID: 7691069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent occupancy of the retinoic acid receptor beta 2 promoter in vivo.
    Dey A; Minucci S; Ozato K
    Mol Cell Biol; 1994 Dec; 14(12):8191-201. PubMed ID: 7969156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.
    Moasser MM; DeBlasio A; Dmitrovsky E
    Oncogene; 1994 Mar; 9(3):833-40. PubMed ID: 8108126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAR beta 2-mediated growth inhibition in HeLa cells.
    Si SP; Lee X; Tsou HC; Buchsbaum R; Tibaduiza E; Peacocke M
    Exp Cell Res; 1996 Feb; 223(1):102-11. PubMed ID: 8635481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoic acid induction of human cellular retinoic acid-binding protein-II gene transcription is mediated by retinoic acid receptor-retinoid X receptor heterodimers bound to one far upstream retinoic acid-responsive element with 5-base pair spacing.
    Aström A; Pettersson U; Chambon P; Voorhees JJ
    J Biol Chem; 1994 Sep; 269(35):22334-9. PubMed ID: 8071361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous retinoic acid receptor beta 2 expression during mesoderm differentiation of P19 murine embryonal carcinoma cells.
    Pratt MA; Crippen CA; Ménard M
    Differentiation; 2000 May; 65(5):271-9. PubMed ID: 10929206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential capacity of wild type promoter elements for binding and trans-activation by retinoic acid and thyroid hormone receptors.
    Williams GR; Harney JW; Moore DD; Larsen PR; Brent GA
    Mol Endocrinol; 1992 Oct; 6(10):1527-37. PubMed ID: 1333048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain.
    Folkers GE; van der Leede BJ; van der Saag PT
    Mol Endocrinol; 1993 Apr; 7(4):616-27. PubMed ID: 8389001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.